Alterity Therapeutics Limited (ASX: ATH)
Sector: Health Care
Market cap: A$61M (as of 2 Nov 2026)
The Company's business is the development of therapeutic drugs for age-related diseases.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 13 Nov 2025 | Regal Funds Management Asia Pte Limited | Entry | ?% → 5.09% | Filing ↗ |
| 14 Oct 2025 | REGAL FUNDS MANAGEMENT PTY LIMITED AND ASSOCIATES | Increase | 13.760% → 14.930% | Filing ↗ |
| 12 May 2025 | The Bank of New York Mellon Corporation (BNYMC) and each Group Entity listed in Annexure A (Group Entity), (together BNYMC Group) | Increase | 24.95% → 26.01% | Filing ↗ |
| 22 Apr 2025 | UBS NOMINEES PTY LTD | Entry | ?% → 29.25% | Filing ↗ |
| 8 Apr 2025 | Regal Partners Funds Management Pty Ltd and its associates | Entry | ?% → 13.76% | Filing ↗ |
Cash and runway
Ask about ATH in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has ATH raised money in the last year, and at what discount?
- What was ATH's latest cash position and runway?
Loading ATH…